Company: SHPH
Filing Date: 2025-02-26
Form Type: 10-K
Source: 0001493152-25-008300
Chunk: 318

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-02-26
Form: 10-K
Item: Item 1A
Chunk 318
---
 ended December 31, 2022 and 2021 and through the
date of the Original Form 8-K, the Company had no “disagreements” (as defined in Regulation S-K, Item 304(a)(1)(iv) and the
related instructions) with the Former Accountant on any matter of accounting principles or practices, financial statement disclosure,
or auditing scope or procedures, which disagreements if not resolved to the satisfaction of the Former Accountant would have caused them
to make reference thereto in their reports on the financial statements for such periods.

There
were no reportable events for the years ended December 31, 2022 or 2021 and through the date of the Original Form 8-K, there were no
reportable events as defined in item 304(a)(1)(v) of Regulation S-K.

As
also disclosed in the Form 8-K, prior to retaining the New Accountant, the Company did not consult with the New Accountant regarding
either: (i) the application of accounting principles to a specified transaction, either contemplated or proposed, or the type of audit
opinion that might be rendered on the Company’s financial statements; or (ii) any matter that was the subject of a “disagreement”
or a “reportable event” (as those terms are defined in Item 304(a)(1)(iv) and (a)(1)(v) of Regulation S-K, respectively).

67

On
March 21, 2023, the Company provided the Former Accountant with the disclosures contained in the Form 8-K disclosing the dismissal of
the Former Accountant and requested in writing that the Former Accountant furnish the Company with a letter addressed to the SEC stating
whether or not they agree with such disclosures. The Former Accountant’s response was filed as Exhibit 16.1 to the Original Form
8-K.

On
May 3, 2024, the SEC entered a cease-and-desist order against our Former Accountant, which resulted in the Re-audit of our financial
statements for the year ended December 31, 2022, which had been audited by our Former Accountant. Since that time and as a result of
the Re-audit, as of July 10, 2024, the Company and the audit committee of our board of directors, in consultation with our current auditor,
Forvis Mazars LLP, concluded that our audited financial statements for the year ended December 31,